Finnish-US food ingredient firm Onego Bio has submitted a Generally Recognized as Safe (GRAS) notification to the FDA for its egg protein Bioalbumen, formulated through precision fermentation. The move bolsters the “first” non-animal egg protein’s entry to the global food market, with the company asserting that its amino acid sequence matches that of natural egg protein.
